Penumbra PEN - Options Chain | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NYSE
Penumbra Inc (PEN)
Penumbra Inc (PEN) Options

Penumbra Inc (PEN)

247.55

0.31

(0.13%)

Closed December 17 3:00PM

Delayed by 15 minutes

247.55

0.00

( 0.00% )

Pre Market: 3:05AM

Delayed by 15 minutes

PEN Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
175.00	70.70	74.30	69.00	72.50	0.00	0.00 %	0	1	-
180.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
185.00	60.70	63.80	21.10	62.25	0.00	0.00 %	0	19	-
190.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
195.00	50.20	54.30	45.55	52.25	0.00	0.00 %	0	16	-
200.00	45.50	49.30	35.65	47.40	0.00	0.00 %	0	62	-
210.00	35.80	39.10	33.60	37.45	0.00	0.00 %	0	134	-
220.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
230.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
240.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
250.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
260.00	0.45	1.15	3.21	0.80	0.00	0.00 %	0	531	-
270.00	1.22	1.75	1.22	1.485	0.00	0.00 %	0	45	-
280.00	1.00	0.75	1.00	0.875	0.00	0.00 %	0	316	-
290.00	1.26	0.75	1.26	1.005	0.00	0.00 %	0	46	-
300.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
310.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
320.00	11.20	0.75	11.20	5.975	0.00	0.00 %	0	7	-
330.00	23.00	0.75	23.00	11.875	0.00	0.00 %	0	23	-
340.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Professional-Grade Tools, for Individual Investors.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
175.00	7.50	0.75	7.50	4.125	0.00	0.00 %	0	9	-
180.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
185.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
190.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
195.00	2.28	0.75	2.28	1.515	0.00	0.00 %	0	212	-
200.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
210.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
220.00	0.30	0.40	0.30	0.35	0.00	0.00 %	0	268	-
230.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
240.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
250.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
260.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
270.00	21.90	24.60	27.00	23.25	0.00	0.00 %	0	1	-
280.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
290.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
300.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
310.00	61.00	64.70	142.20	62.85	-0.00001	0.00 %	0	0	-
320.00	71.00	74.80	124.50	72.90	0.00	0.00 %	0	0	-
330.00	81.00	84.90	119.50	82.95	0.00	0.00 %	0	0	-
340.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUKKNukkleus Inc	US$ 21.52 (81.14%)	454.52k
PRZOParaZero Technologies Ltd	US$ 2.735 (78.76%)	475.38k
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.5301 (58.76%)	4.15M
SFHGSamfine Creation Holdings Group Ltd	US$ 0.89 (30.23%)	634
CEROCERo Therapeutics Holdings Inc	US$ 0.0751 (22.91%)	2.13M
NIVFNewGenIvf Group Ltd	US$ 0.30 (-29.20%)	27.38k
PTPIPetros Pharmaceuticals Inc	US$ 0.4078 (-18.44%)	165.57k
KWEKWESST Micro Systems Inc	US$ 0.691 (-17.74%)	16.03k
PRTGPortage Biotech Inc	US$ 7.75 (-14.27%)	4.03k
BFINBankFinancial Corporation	US$ 11.00 (-14.00%)	100
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.5301 (58.76%)	4.15M
CEROCERo Therapeutics Holdings Inc	US$ 0.0751 (22.91%)	2.13M
LAESSEALSQ Corporation	US$ 2.76 (-7.38%)	914.11k
RGTIRigetti Computing Inc	US$ 11.90 (6.92%)	868.51k
RZLVRezolve AI Ltd	US$ 3.94 (19.76%)	767.5k

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

... ALL NEWS IS GOOD? ... $PEN

CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients

davidsson10

davidsson10 4 years ago

https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020

TREND1

TREND1 9 years ago

IPO INFO

http://www.marketwatch.com/tools/ipo-calendar

TREND1

TREND1 9 years ago

IPO NOW HAS SYMBOL
Penumbra PEN

TREND1

TREND1 9 years ago

IPO should be out soon.
no symbol yet.

Toyota Motor Finance Net...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions